Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1810 1
1813 1
1903 1
1904 1
1915 1
1919 1
1923 2
1928 1
1929 1
1933 2
1945 4
1946 10
1947 8
1948 13
1949 33
1950 30
1951 54
1952 67
1953 74
1954 77
1955 66
1956 107
1957 61
1958 92
1959 85
1960 101
1961 152
1962 126
1963 90
1964 59
1965 142
1966 176
1967 225
1968 233
1969 290
1970 527
1971 578
1972 519
1973 441
1974 383
1975 380
1976 374
1977 330
1978 316
1979 289
1980 299
1981 340
1982 335
1983 411
1984 540
1985 534
1986 654
1987 801
1988 772
1989 898
1990 1020
1991 1006
1992 1082
1993 1201
1994 1208
1995 1324
1996 1359
1997 1635
1998 1670
1999 1930
2000 2020
2001 1995
2002 2317
2003 2645
2004 2827
2005 2973
2006 3554
2007 3805
2008 4069
2009 4353
2010 4899
2011 5363
2012 5826
2013 6272
2014 6434
2015 7045
2016 7470
2017 7833
2018 8097
2019 8448
2020 9923
2021 10693
2022 10585
2023 10279
2024 4546

Text availability

Article attribute

Article type

Publication date

Search Results

152,418 results

Results by year

Filters applied: . Clear all
Page 1
Challenges in the diagnosis of Parkinson's disease.
Tolosa E, Garrido A, Scholz SW, Poewe W. Tolosa E, et al. Lancet Neurol. 2021 May;20(5):385-397. doi: 10.1016/S1474-4422(21)00030-2. Lancet Neurol. 2021. PMID: 33894193 Free PMC article. Review.
Parkinson's disease is the second most common neurodegenerative disease and its prevalence has been projected to double over the next 30 years. An accurate diagnosis of Parkinson's disease remains challenging and the characterisati …
Parkinson's disease is the second most common neurodegenerative disease and its prevalence has been projected to …
Parkinson's disease.
Kalia LV, Lang AE. Kalia LV, et al. Lancet. 2015 Aug 29;386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. Epub 2015 Apr 19. Lancet. 2015. PMID: 25904081 Review.
Parkinson's disease is a neurological disorder with evolving layers of complexity. ...In this Seminar, we review these complexities and challenges of Parkinson's disease....
Parkinson's disease is a neurological disorder with evolving layers of complexity. ...In this Seminar, we review these …
Parkinson's Disease and Parkinsonism.
Hayes MT. Hayes MT. Am J Med. 2019 Jul;132(7):802-807. doi: 10.1016/j.amjmed.2019.03.001. Epub 2019 Mar 16. Am J Med. 2019. PMID: 30890425 Review.
Parkinson's disease is a progressive neurodegenerative disease characterized by tremor and bradykinesia and is a common neurologic ailment. ...There are a number of other extrapyramidal conditions that can make the diagnosis challenging. Unlike other n …
Parkinson's disease is a progressive neurodegenerative disease characterized by tremor and bradykinesia and is a …
Parkinson's disease: a review.
Beitz JM. Beitz JM. Front Biosci (Schol Ed). 2014 Jan 1;6(1):65-74. doi: 10.2741/s415. Front Biosci (Schol Ed). 2014. PMID: 24389262 Free article. Review.
Parkinson's Disease is the second most common progressive neurodegenerative disorder affecting older American adults and is predicted to increase in prevalence as the United States population ages. Resulting from a pathophysiologic loss or degeneration of dop …
Parkinson's Disease is the second most common progressive neurodegenerative disorder affecting older American adults an …
Parkinson's Disease in Women and Men: What's the Difference?
Cerri S, Mus L, Blandini F. Cerri S, et al. J Parkinsons Dis. 2019;9(3):501-515. doi: 10.3233/JPD-191683. J Parkinsons Dis. 2019. PMID: 31282427 Free PMC article. Review.
Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's disease (PD). Risk of developing PD is twice as high in men than women, but women have a higher mortality rate and faster progres …
Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's …
Epidemiology of Parkinson's disease.
Tysnes OB, Storstein A. Tysnes OB, et al. J Neural Transm (Vienna). 2017 Aug;124(8):901-905. doi: 10.1007/s00702-017-1686-y. Epub 2017 Feb 1. J Neural Transm (Vienna). 2017. PMID: 28150045 Review.
Parkinson's disease (PD) affects 1-2 per 1000 of the population at any time. ...Increasing knowledge on genetic and environmental risk factors of PD will probably elucidate the cause of this disease within the near future....
Parkinson's disease (PD) affects 1-2 per 1000 of the population at any time. ...Increasing knowledge on genetic and env …
Parkinson's Disease.
Reich SG, Savitt JM. Reich SG, et al. Med Clin North Am. 2019 Mar;103(2):337-350. doi: 10.1016/j.mcna.2018.10.014. Epub 2018 Dec 3. Med Clin North Am. 2019. PMID: 30704685 Review.
The diagnosis of Parkinson disease (PD) is based on the presence of bradykinesia and either resting tremor or rigidity and there should be no features from the history or examination to suggest an alternative cause of parkinsonism. ...
The diagnosis of Parkinson disease (PD) is based on the presence of bradykinesia and either resting tremor or rigidity and the …
The epidemiology of Parkinson's disease: risk factors and prevention.
Ascherio A, Schwarzschild MA. Ascherio A, et al. Lancet Neurol. 2016 Nov;15(12):1257-1272. doi: 10.1016/S1474-4422(16)30230-7. Epub 2016 Oct 11. Lancet Neurol. 2016. PMID: 27751556 Review.
Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Parkinson's disease. Increased risk of Parkinson's disease has been associated with exposure to pestici …
Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Pa …
Motor assessment in Parkinson`s disease.
Opara J, Małecki A, Małecka E, Socha T. Opara J, et al. Ann Agric Environ Med. 2017 Sep 21;24(3):411-415. doi: 10.5604/12321966.1232774. Epub 2017 May 11. Ann Agric Environ Med. 2017. PMID: 28954481 Free article. Review.
Parkinson's disease (PD) is one of most disabling disorders of the central nervous system. ...These are many clinimetric scales used in Parkinson`s Disease, the most popular being the Hoehn and Yahr stages of progression of the disease …
Parkinson's disease (PD) is one of most disabling disorders of the central nervous system. ...These are many clinimetri …
Progress towards therapies for disease modification in Parkinson's disease.
Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T. Vijiaratnam N, et al. Lancet Neurol. 2021 Jul;20(7):559-572. doi: 10.1016/S1474-4422(21)00061-2. Lancet Neurol. 2021. PMID: 34146514 Review.
The development of interventions to slow or halt the progression of Parkinson's disease remains a priority for patients and researchers alike. ...Better understanding of Parkinson's disease pathogenesis associated with advances in laborat …
The development of interventions to slow or halt the progression of Parkinson's disease remains a priority for patients …
152,418 results
You have reached the last available page of results. Please see the User Guide for more information.